Title: Research Communications of the 27(th) ECVIM-CA Congress: Intercontinental, Saint Julian's, Malta, 14th to 16th September 2017 Document date: 2017_11_7
ID: roslkxeq_575
Snippet: Disclosures: No disclosures to report. Numerous portable blood glucose meters (PBGMs) have been developed during the last decade, the majority of which is designed for use in humans. Recently one glucometer (Gluco Calea, WellionVet; GC) and one glucose-ketones meter (Belua, WellionVet; BE) have been developed for use in veterinary medicine. The aims of this study were to assess the accuracy and precision of these devices in feline venous and capi.....
Document: Disclosures: No disclosures to report. Numerous portable blood glucose meters (PBGMs) have been developed during the last decade, the majority of which is designed for use in humans. Recently one glucometer (Gluco Calea, WellionVet; GC) and one glucose-ketones meter (Belua, WellionVet; BE) have been developed for use in veterinary medicine. The aims of this study were to assess the accuracy and precision of these devices in feline venous and capillary blood samples based on ISO 15197:2013 and to evaluate packed cell volume (PCV) interferences. Samples were obtained from 29 non anemic cats (PCV 30-47%) and 18 anemic cats (PCV<30%) divided into three glycemic ranges: high (>140 mg/dL), medium (90-139 mg/dL), and low (<90 mg/dL). Paired measurements of glucose and 3-a° z-hydroxybutyrate (3-HB) from capillary and venous blood samples were determined using the two devices and compared with the results of reference methods (enzymatic hexokinase and 3-HB-dehydrogenase, respectively) obtained by an automated chemistry analyzer (Beckman-Coulter AU480). Linear regression, Bland Altman plots and the Parkes error grid analysis (EG) were used to assess the accuracy. PCV interferences for glucose measurement were assessed comparing the differences between PBGMs readings and reference method values in anemic and non-anemic cats. To assess within-run precision, glucose concentrations obtained from 14 samples, belonging to the three glycemic ranges, were measured 10 times within 10 minutes. Between-day precision was assessed by testing each manufacturer's glucose control solution over 10 consecutive days. P < 0.05 was considered significant.
Search related documents:
Co phrase search for related documents- EG grid analysis error and glucose 10 consecutive day control solution: 1
- EG grid analysis error and glucose measurement: 1
- EG grid analysis error and grid analysis: 1
- EG grid analysis error and linear regression: 1
- EG grid analysis error and reference method: 1
- EG grid analysis error and run precision: 1
- EG grid analysis error and run precision assess: 1
- enzymatic hexokinase and glucose 10 consecutive day control solution: 1
- enzymatic hexokinase and glucose measurement: 1
- enzymatic hexokinase and grid analysis: 1
- enzymatic hexokinase and linear regression: 1
- enzymatic hexokinase and reference method: 1
- enzymatic hexokinase and run precision: 1
- enzymatic hexokinase and run precision assess: 1
- glucose 10 consecutive day control solution and grid analysis: 1
- glucose 10 consecutive day control solution and linear regression: 1
- glucose 10 consecutive day control solution and reference method: 1
- glucose 10 consecutive day control solution and run precision: 1
- glucose 10 consecutive day control solution and run precision assess: 1
Co phrase search for related documents, hyperlinks ordered by date